Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

By Nishimura Reiki  

Breast Cancer, Vol. 17, Iss. 4, 2010-10 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1046-1054

Spandidos Publications

Access to resources Recommend Favorite

Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancer

By            

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 2025-2033

Spandidos Publications

Access to resources Recommend Favorite

Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone

By Kurebayashi Junichi   Kanomata Naoki   Shimo Toshiro   Yamashita Tetsumasa   Aogi Kenjiro   Nishimura Rieko   Shimizu Chikako   Tsuda Hitoshi   Moriya Takuya   Sonoo Hiroshi  

Breast Cancer, Vol. 21, Iss. 2, 2014-03 ,pp. : 214-222

Springer Publishing Company

Access to resources Recommend Favorite

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

By Masuda Hiroko   Masuda Norikazu   Kodama Yoshinori   Ogawa Masami   Karita Michiko   Yamamura Jun   Tsukuda Kazunori   Doihara Hiroyoshi   Miyoshi Shinichiro   Mano Masayuki   Nakamori Shoji   Tsujinaka Toshimasa  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 911-917

Springer Publishing Company

Access to resources Recommend Favorite